Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 6Breast Neoplasms 5Prostatic Neoplasms 4Melanoma 4Gliosarcoma 3Glioblastoma 3Carcinoma, Ovarian Epithelial 3Brain Neoplasms 3Stomach Neoplasms 2Sarcoma 2Salivary Gland Neoplasms 2Rectal Neoplasms 2Pancreatic Neoplasms 2Oligodendroglioma 2Lymphoma, Non-Hodgkin 2Lymphoma, Follicular 2Lymphoma, B-Cell, Marginal Zone 2Glioma 2Fallopian Tube Neoplasms 2Ependymoma 2Colorectal Neoplasms 2Astrocytoma 2Waldenstrom Macroglobulinemia 1Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Unspecified Childhood Solid Tumor, Protocol Specific 1Tongue Neoplasms 1Testicular Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1

Interventions

Radiotherapy 7Cisplatin 7Irinotecan 5Fluorouracil 5pembrolizumab 4Docetaxel 4Paclitaxel 3Oxaliplatin 3durvalumab 2Radiation 2Nivolumab 2Magnetic Resonance Spectroscopy 2Leucovorin 2Drug Therapy 2Carboplatin 2vandetanib 1toripalimab 1tislelizumab 1spartalizumab 1ribociclib 1obinutuzumab 1naptumomab estafenatox 1matuzumab 1futibatinib 1adavosertib 1Vorinostat 1Topotecan 1Taxes 1Surgical Procedures, Operative 1Sunitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Adenocarcinoma Of Esophagus × Immunohistochemistry × Clear all
NCT01561014 2018-07-02

Oxaliplatin, Fluorouracil, Erlotinib Hydrochloride, and Radiation Therapy Before Surgery and Erlotinib Hydrochloride After Surgery in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction

Wake Forest University Health Sciences

Phase 1 Completed
9 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡